Drugmaker Eli Lilly and Co. spent $1.59 million in the second quarter lobbying the federal government on an array of trade issues and health care reform.

The Indianapolis-based drugmaker lobbied on German and Greek pricing reforms and Polish and Italian market access. It lobbied on counterfeit medicines, Russian data exclusivity and financial derivatives according to a report filed with the clerk of the House of Representatives.

Lilly also lobbied on Medicaid and Medicare issues and hospital discounts tied to health care reform, which was passed in March by Congress and aims to cover millions of uninsured people.

The drugmaker's second-quarter spending total dropped 56 percent from the same quarter of 2009 and also represented a decrease from the $2.3 million it spent in the 2010 first quarter.

Besides Congress, Lilly also lobbied the U.S. Trade Representative, the Patent and Trademark Office, the Food and Drug Administration, and the departments of Health and Human Services, Commerce, State and Agriculture.

BW Extras


Most Popular Stories

  1. Three Types of People to Fire Immediately
  2. Lego Is for Girls
  3. Google's Spreading Tentacles of Influence
  4. Gatorade Goes Back to the Lab
  5. Impress Potential Investors in 12 Steps

RSS Feed: Most Read Stories

  1. Three Types of People to Fire Immediately
  2. Which Is America's Best City?
  3. Lego Is for Girls
  4. Top B-School Stories of 2011
  5. Professional Women and a Secure Retirement

RSS Feed: Most E-mailed Stories

  1. Facebook's Holocaust Controversy
  2. America's Best, Affordable Places to Raise Kids
  3. Bullpen Diaries

RSS Feed: Most Discussed Stories

Most Popular Multimedia

  1. Tuition-Free Colleges
  2. Twenty Tips for First-Time Managers
  3. The Best Design Schools in the World

RSS Feed: Most Popular Slide Shows

BW Mall - Sponsored Links

Buy a link now!